Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Friedberg

Showing results (161-170 of 300) with videos related to

Pageof 30
Sort By:
Leukemia & Lymphoma|November 22, 2011
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national databaseGregory A Abel, Ann Vanderplas, Maria A Rodriguez, et al.
Blood|March 11, 2015
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemiaJennifer R Brown, Jacqueline C Barrientos, Paul M Barr, et al.
American Journal of Hematology|December 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806Daniel O Persky, Hongli Li, Lisa M Rimsza, et al.
Cancer|March 23, 2024
High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCTLuke J Peppone, Amber S Kleckner, Chunkit Fung, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Haematologica|February 24, 2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohortLisa M Rimsza, Hongli Li, Rita M Braziel, et al.
Leukemia|October 31, 2020
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphomaClive S Zent, Michael T Brady, Carolyne Delage, et al.
Blood|September 18, 2015
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and olderAndres Forero-Torres, Beata Holkova, Jerome Goldschmidt, et al.
Haematologica|July 14, 2022
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001Deborah M Stephens, Hongli Li, Louis S Constine, et al.
Blood Advances|July 6, 2022
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysisDanny Luan, Tolulope Fatola, Ahmed Toure, et al.
Pageof 30

Showing results (161-170 of 300) with videos related to

Sort By:
Pageof 30
Leukemia & Lymphoma|November 22, 2011
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national databaseGregory A Abel, Ann Vanderplas, Maria A Rodriguez, et al.
Blood|March 11, 2015
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemiaJennifer R Brown, Jacqueline C Barrientos, Paul M Barr, et al.
American Journal of Hematology|December 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806Daniel O Persky, Hongli Li, Lisa M Rimsza, et al.
Cancer|March 23, 2024
High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCTLuke J Peppone, Amber S Kleckner, Chunkit Fung, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Haematologica|February 24, 2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohortLisa M Rimsza, Hongli Li, Rita M Braziel, et al.
Leukemia|October 31, 2020
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphomaClive S Zent, Michael T Brady, Carolyne Delage, et al.
Blood|September 18, 2015
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and olderAndres Forero-Torres, Beata Holkova, Jerome Goldschmidt, et al.
Haematologica|July 14, 2022
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001Deborah M Stephens, Hongli Li, Louis S Constine, et al.
Blood Advances|July 6, 2022
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysisDanny Luan, Tolulope Fatola, Ahmed Toure, et al.
Pageof 30